Corrigendum to ‘Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature’ (Mult. Scler. Relat. Disord. (2016) 9 (158–162) (S2211034816301250) (10.1016/j.msard.2016.07.015))

Elena Grebenciucova, Anthony T. Reder, Jacqueline Bernard

Research output: Contribution to journalComment/debate

Abstract

The authors regret that there was an error on p. 159, first paragraph of the above article. The words ‘cryptococcal antigen/antigenemia’ should be ‘cryptococcal antibody’ and should be read as following: ‘Different geographic populations may exhibit different levels of antibody positivity (Goldman et al., 2001), A study on pre-solid organ transplant patients showed that cryptococcal antibody positivity prior to the transplant was evident in 52% of patients who later developed active infection and correlated with the risk and timing of development of cryptoccal meningitis post-transplant. Patients who were antibody-positive prior to the transplantation developed cryptococcocal infection significantly earlier after transplant than patients without preexistent antibody positivity (5.6 +/- 3.4 months compared to 40.6 +/- 63.8 months) (Saha et al., 2007)’. The authors would like to apologize for any inconvenience caused.

Original languageEnglish (US)
Number of pages1
JournalMultiple Sclerosis and Related Disorders
Volume10
DOIs
StatePublished - Nov 1 2016
Externally publishedYes

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Corrigendum to ‘Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature’ (Mult. Scler. Relat. Disord. (2016) 9 (158–162) (S2211034816301250) (10.1016/j.msard.2016.07.015))'. Together they form a unique fingerprint.

  • Cite this